LY3200882
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY3200882, covering 2025-09-05 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3200882 in Participants With Solid Tumors [Phase 1]